Completed OBSERVATIONAL NCT01470729

Biomarkers in Autosomal Dominant Cerebellar Ataxia (BIOSCA)

Identification of Biomarkers in Patients With Autosomal Dominant Cerebellar Ataxia

Sponsor: Assistance Publique - Hôpitaux de Paris

Conditions Episodic Ataxia, Type 7 Spinocerebellar Ataxia Type 1 Spinocerebellar Ataxia Type 2 Spinocerebellar Ataxia, Autosomal Recessive 3

Interventions metabolic and imaging biomarkers in SCA1,2,3 and 7 patients

Updated 11 times since 2017 Last updated: Sep 4, 2019 Started: Nov 30, 2011 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Episodic Ataxia, Type 7 and Spinocerebellar Ataxia Type 1 and is currently completed. Assistance Publique - Hôpitaux de Paris leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 6 earlier versions

Oct 2019 — Nov 2020 [monthly]

Completed
Jun 2018 — Oct 2019 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France